NEPTUNE DIGITAL ASSETS CORP
NPPTF
Intchains Group
ICG
Bitdeer Technologies
BTDR
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.